Cagent Vascular News and Activities

Acquisition, funding and merger involving Cagent Vascular.

• Cagent Vascular has just announced a $41 Million fundraising (posted on May 20 2026).

View the org chart displaying its 18 main executives

Most searched biographies at Cagent Vascular

• Brian Walsh, Chairman of the Board and Chief Executive Officer
• Jay Brumfield, Director
• Casey Tansey, Director

Popular executive movements at Cagent Vascular

• Dan Rolfes who was Accounting Manager, becomes Commercial Finance Manager  (posted on March 2 2026).
• Lauren Pfeiffer who was Director, Marketing, Communications and Branding, becomes Director of Global Commercial Operations  (posted on March 2 2026).

Create your alert
to follow the executive moves at Cagent Vascular.

Cagent Vascular has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).
• Scribe Therapeutics has filed its IPO. Its stock ticker will be SCTX. (posted on July 7 2026).
• ClearOne Communications has announced the acquisition of Cortigent  (posted on July 6 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Cagent Vascular

• News & Media Releases — Cagent Vascular | Serration Remodeling Therapy
• Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy of Serration Remodeling Therapy™ in the Most Challenging Arteries Below-the-Ankle — Cagent Vascular | Serration Remodeling Therapy
• Saving Limbs Where Others Stop: Cagent Vascular Announces Landmark…
• Cagent Vascular Expands Serranator Product Line with Launch of 7.0 mm…
• WDEF News 12: New Tech from Cagent Vascular brings Serrated Edge to…
• Cagent Vascular Initiates Patient Enrollment in the Serranator® vs.…
• Cagent Vascular and 3comma Medical Announce Strategic Partnership to…
• Paul Wilson Appointed as Chief Commercial Officer to Drive Growth and…
• Cagent Vascular Announces Launch of New Product Serranator SL-PRO for…
• Cagent Vascular Initiates the Serranator® POINT FORCE Observational…
• View more press releases Close

Social media about Cagent Vascular

• Cagent Vascular on Wikipedia, Google News & Yahoo Finance
• Cagent Vascular on LinkedIn, X (Twitter) & YouTube